Ramifications Of Big Stem Cell Investment – Seeking Alpha
Seeking Alpha |
Ramifications Of Big Stem Cell Investment
Seeking Alpha The new venture will focus on breakthrough treatments based on the latest stem cell technology with an initial focus on cardiovascular and neurological conditions. Bayer and Versant committed $225 million in a Series A financing providing the company … |
